Tuesday, February 19, 2008

NNVC

The market cap of NNVC is about $50M. Read today's press release, these tests were made not by NNVC, but by the US Army. Now read what I have highlighted in bold. Finally, ask yourself how much longer this company will be valued at under $100M......and then how much longer it will be valued at under $500M?

A

Nanoviricides Found Highly Effective against Ebola by USAMRIID

Tuesday February 19, 7:00 am ET

Broad-spectrum Nanoviricides Demonstrated to Have Excellent Efficacy in Cell Culture Studies

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that the broad-spectrum nanoviricides™ drug candidates were found to be highly effective against the deadly Ebola virus in initial cell culture studies by scientists at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

“The fact that the same drug candidates that were highly effective against common influenza and rabies in animal studies and bird flu (H5N1) in cell culture studies were also found to be highly effective against the deadly Ebola virus clearly indicates that these nanoviricides are truly broad-spectrum,” said Eugene Seymour, MD, MPH, CEO of the Company, about the results.

“We have identified common mechanisms by which these very different types of viruses bind to cells and enter cells. We have designed the nanoviricides to display the same features that these viruses look for on the host cell. Our nanoviricides essentially mimic the host cell. We believe this results in fooling the virus to bind to the nanoviricide and be destroyed,” said Anil R. Diwan, Ph.D., President of the Company, adding, “We now have a phenomenal streak of successes of this biomimetic technology as broad-spectrum antivirals.”


Animal studies to test the efficacy of these nanoviricides drug candidates against Ebola infection will be undertaken shortly, according to USAMRIID scientists.

USAMRIID and NanoViricides entered into a Material Transfer Agreement (MTA) in October, 2007. The resulting joint R&D effort enables USAMRIID scientists to test the efficacy of several NanoViricides, Inc. anti-viral nanomedicines against deadly hemorrhagic fever viruses at the Ft. Detrick, Maryland BSL4 facilities.

It is hoped that success against the deadly Ebola virus will lead to further success against other virulent pathogens such as hanta viruses, Marburg virus, Junin virus, Machupo virus, and Rift Valley fever virus. There are currently no FDA-approved treatment options for these diseases.

About USAMRIID

USAMRIID, located at Fort Detrick, Maryland, is the lead medical research laboratory for the U.S. Biological Defense Research Program, and plays a key role in national defense and in infectious disease research. The Institute’s mission is to conduct basic and applied research on biological threats resulting in medical solutions (such as vaccines, drugs and diagnostics) to protect the warfighter. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Materiel Command.

The Institute is working to develop therapeutics for a number of agents, such as Ebola virus, plague, several toxins, and orthopoxviruses.

The information contained in this press release does not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.

About NanoViricides:

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, hepatitis C, rabies, and dengue fever, among others.

6 comments:

sayeed said...

how long before the market realizes the worth of NNVC? It's been sitting steady at 0.40 for a long time now...

Allan said...

how long before the market realizes the worth of NNVC? It's been sitting steady at 0.40 for a long time now...

If we knew that answer, we could stay in case until just before the market gets slapped in the face and then pull the trigger. Since we don't know the answer, the risk seems to be in sitting this one out.

Anonymous said...

The current Form 10QSB has the following in the last paragraph: "On January 3, 2008 the Company signed an agreement with a consultant to provide public relations and strategic communications advice and services."

Looks like they are looking to increase the profile of the company and therefore increase the stock price.

Anonymous said...

.4 to .65 in 4 days is not bad!
curt

Anonymous said...

Still doing the NNVC thing after all these years? This was a very early high hitter for this blog, right...the bird flu craze of late 2005? NNVC the 'We cure everything company'

Allan said...

Still doing the NNVC thing after all these years? This was a very early high hitter for this blog, right...the bird flu craze of late 2005? NNVC the 'We cure everything company'

There have been several buying opportunities where NNVC popped anywhere from 10-40% in a matter of days. Identifying those opportunities is one of the attractions I have to this stock. There is also a long term attraction, the real payoff, 1,000% or better, if this technology is for real.

A